ProBDNF expression was increased in all tested immune cells, including CD3+, CD4+CD8-, and CD4-CD8+ T cells, as well as CD19+ B cells, from MS patients compared to healthy donors (Figure 1A and Table S1). This evidence concerns the gene CD19 and myeloid sarcoma.